Expertise in
5
conditions

Maxime D. Fontanilles

Le Havre, FR 
Expertise in
5
conditions
Le Havre, FR 

Overview

Maxime Fontanilles practices practicing medicine in Le Havre, France.

Mr. Fontanilles is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.

He is actively involved in clinical research, co-authoring 38 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Le Havre, 76600, France
Other Locations
Rouen, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study
Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study
Enrollment Status: Completed
Publish Date: July 02, 2026
Intervention Type: Other
Study Phase: Not Applicable
A European, Multi-centre Phase II Trial of Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck (HNSCC)
A European, Multi-centre Phase II Trial of Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck (HNSCC)
Enrollment Status: Completed
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Atezolizumab, Bevacizumab
Study Phase: Phase 2
View 1 Less Clinical Trial

38 Total Publications

Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective study.
Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective study.
Journal: Radiation oncology (London, England)
Published: May 19, 2025

Frequently Asked Questions about Maxime D. Fontanilles

Is Maxime D. Fontanilles a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Maxime D. Fontanilles is classified as an Advanced expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Maxime D. Fontanilles participate in research or clinical trials?

Yes. Maxime D. Fontanilles has published 38 articles and abstracts on conditions like Glioblastoma. You can view a list of Maxime D. Fontanilles's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fontanilles's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile